◆ TickerVerdict
StocksGuidesAbout
Home / About / Abdelali El Amrani
Abdelali El Amrani

Abdelali El Amrani

Founder and publisher, TickerVerdict

LinkedIn profile · contact@tickerverdict.com

Abdelali El Amrani founded TickerVerdict and is responsible for everything it publishes: the stock comparisons, the guides, and the rules both are built under. He runs the site through Servolia LLC, the company through which he operates his online businesses.

What he is responsible for

  • The methodology. Which figures a comparison uses, how the six-factor score is decided, and which numbers are withheld because they cannot be interpreted. How the score works.
  • What gets published. Which company pairs are compared and which guides go live — TickerVerdict publishes a small set of pages it can stand behind rather than every pair it could generate.
  • Corrections. Messages sent through the contact page or to contact@tickerverdict.com reach him directly.

The rules every page is published under

  • Every company figure comes from that company's own SEC filings, and every price is a dated exchange close. Nothing is estimated, and nothing comes from analyst forecasts.
  • A number that means nothing for a business — EV/EBITDA for a bank, a P/E for a company that lost money — is left out, and the page says why. See the numbers we refuse to print.
  • The written analysis is drafted with the help of an AI model and says so. An automated check compares every figure in it with the filings data, and a page whose numbers do not match cannot be published.
  • No company, broker or advertiser can pay to be covered, scored or ranked.

The full version is the editorial policy.

What he is not

Abdelali is not a licensed financial adviser, broker or registered investment adviser, and TickerVerdict does not give personal investment advice. The site compares what companies have reported; what to do with that is your decision, ideally made with a qualified adviser who knows your circumstances.

Guides he has published

  • Price-to-sales explained: what a dollar of revenue is worth, and why the margin decides itWhat price-to-sales measures, the one equation that ties it to the P/E, and why a low multiple can mean cheap or simply thin margins, shown with real companies.
  • Balance-sheet risk: net debt, interest cover and the current ratioThe three numbers that show whether a company can carry its debt, how to read each one, and what they reveal about Pfizer, Intel, Disney and Palantir.
  • Big tech compared: Apple, Microsoft, Alphabet, Meta and Amazon by the numbersThe largest technology companies on one table — growth, margins, the cash cost of the AI build-out, and what each valuation assumes — built from their SEC filings.
  • Consumer staples compared: Coca-Cola, PepsiCo and the price of predictabilityCoca-Cola and PepsiCo on the same filings: slow growth, large dividends and steady debt, and why the market pays so much more for Coca-Cola's profits.
  • Dividends vs buybacks: how companies hand cash back, and how to judge itDividend yield, payout ratio and buyback yield explained with real companies, why a high yield can be a warning, and how to tell whether a payout is sustainable.
  • EV and auto stocks compared: Tesla, Ford, GM, Rivian and LucidFive carmakers on the same filings: why Tesla is valued like a tech company, what the 19–21% cash yields at Ford and GM hide, and how fast Rivian and Lucid burn cash.
  • EV/EBITDA explained: valuing the whole business, not just the sharesHow enterprise value and EBITDA work, why EV/EBITDA and P/E can disagree by a mile, its blind spots, and what the gap tells you about Alphabet, Amazon and Micron.
  • Free cash flow yield: the valuation measure that is hardest to fakeWhy cash beats reported earnings, how free cash flow yield works, and what the gap between profit and cash reveals at Apple, Amazon, Microsoft and Salesforce.
  • Healthcare stocks compared: Eli Lilly, UnitedHealth and PfizerTwo drugmakers at opposite ends of a growth cycle and an insurer with razor-thin margins: what Lilly, Pfizer and UnitedHealth's filings really show.
  • How the six-factor score works — and where it falls shortThe exact rules behind every TickerVerdict verdict: what each of the six factors measures, how ties are decided, a worked example, and the score's real limits.
  • How to compare bank stocks: JPMorgan vs Bank of AmericaWhy the usual ratios fail for banks, how price-to-book and return on equity work together, what our bank pages show, and the numbers you still need from the filings.
  • How to read a 10-K: where every number on TickerVerdict comes fromA practical walk through a company's annual report — the sections worth your time, the three statements, and how filings become trailing-twelve-month figures.
  • Oil stocks compared: Exxon Mobil, Chevron and the commodity cycleExxon Mobil and Chevron on the same filings: why both show shrinking growth, how they turn oil prices into cash, and what their dividends and buybacks rest on.
  • Operating margin: why Nvidia keeps 65 cents of each dollar and Ford keeps noneWhat operating margin measures, why it differs so much between business models, and what Coca-Cola, PepsiCo, Nvidia, Intel and the carmakers teach about pricing power.
  • Revenue growth vs EPS growth: why they diverge and which to trustHow three-year growth rates are calculated, why earnings can grow ten times faster than sales or shrink while sales rise, and what Salesforce, Meta and Tesla show.
  • ROE vs ROIC: why Apple's 149% return on equity says little and its ROIC says a lotHow return on equity and return on invested capital are calculated, why buybacks and debt inflate ROE, and which companies earn high returns on capital.
  • Semiconductor stocks compared: Nvidia, Broadcom, AMD, Micron, Intel and moreSeven chip companies on the same filings data — who makes the money in the AI boom, why margins range from 75% to below zero, and what each valuation is betting on.
  • The numbers we refuse to print, and why that makes the rest worth trustingForward P/E, a P/E for a loss-maker, growth across a loss, EV/EBITDA for a bank: every figure TickerVerdict withholds, with the real companies it applies to.
  • The P/E ratio, explained — and five ways it misleadsWhat price-to-earnings really measures, why a low P/E is not the same as cheap, and five traps shown with real companies, from Tesla at 403 times to Micron at 12.

Contact

Email contact@tickerverdict.com, use the contact form, or find him on LinkedIn. By post: Servolia LLC, 30 N Gould St Ste R, Sheridan, WY 82801, USA.

Keep TickerVerdict one tap away

Add it to your home screen and it opens like an app — full screen, no browser bar — so the comparisons and guides are one tap away. No app store, no account, nothing to download.

Open your browser menu and choose “Install app” or “Add to Home Screen”.

Compare
  • All stock comparisons
  • Semiconductors
  • Big tech
  • Carmakers & EVs
  • Banks
  • Healthcare
  • Consumer staples
  • Oil & gas
Learn
  • All guides
  • How the score works
  • Numbers we don't print
  • How to read a 10-K
  • Valuation cheat sheet
Company
  • About TickerVerdict
  • Abdelali El Amrani
  • Editorial policy
  • Contact
  • LinkedIn
Legal
  • Privacy policy
  • Terms of use
  • Data protection complaint

TickerVerdict provides factual data comparisons for informational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security. Figures may be delayed; verify with your broker before investing. Capital is at risk.

© 2026 TickerVerdict · Data-led stock comparisons · Operated by Servolia LLC, a Wyoming limited liability company · 30 N Gould St Ste R, Sheridan, WY 82801, USA